JP2020508992A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020508992A5 JP2020508992A5 JP2019544845A JP2019544845A JP2020508992A5 JP 2020508992 A5 JP2020508992 A5 JP 2020508992A5 JP 2019544845 A JP2019544845 A JP 2019544845A JP 2019544845 A JP2019544845 A JP 2019544845A JP 2020508992 A5 JP2020508992 A5 JP 2020508992A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- alcohol
- group
- acne
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims description 38
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 20
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 18
- 235000019441 ethanol Nutrition 0.000 claims description 15
- 229930003827 cannabinoid Natural products 0.000 claims description 14
- 239000003557 cannabinoid Substances 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 229920001451 polypropylene glycol Polymers 0.000 claims description 12
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 11
- 206010000496 acne Diseases 0.000 claims description 11
- 229920001223 polyethylene glycol Polymers 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 229940065144 cannabinoids Drugs 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 230000002265 prevention Effects 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 230000000699 topical effect Effects 0.000 claims description 6
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims description 5
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 4
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims description 4
- 229950011318 cannabidiol Drugs 0.000 claims description 4
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims description 4
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims description 4
- 150000002191 fatty alcohols Chemical class 0.000 claims description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 3
- -1 aliphatic alcohols Chemical class 0.000 claims description 3
- 239000013557 residual solvent Substances 0.000 claims description 3
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 claims description 2
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 claims description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims description 2
- 229940055577 oleyl alcohol Drugs 0.000 claims description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims 1
- 230000035876 healing Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022166140A JP2022185150A (ja) | 2017-02-15 | 2022-10-17 | ざ瘡の処置のためのカンナビノイドの製剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762459313P | 2017-02-15 | 2017-02-15 | |
| AU2017900493 | 2017-02-15 | ||
| AU2017900493A AU2017900493A0 (en) | 2017-02-15 | Formulations of Cannabinoids for the Treatment of Acne | |
| US62/459,313 | 2017-02-15 | ||
| PCT/AU2018/050045 WO2018148786A1 (en) | 2017-02-15 | 2018-01-24 | Formulations of cannabinoids for the treatment of acne |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022166140A Division JP2022185150A (ja) | 2017-02-15 | 2022-10-17 | ざ瘡の処置のためのカンナビノイドの製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020508992A JP2020508992A (ja) | 2020-03-26 |
| JP2020508992A5 true JP2020508992A5 (cg-RX-API-DMAC7.html) | 2020-12-17 |
Family
ID=67766784
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019544845A Withdrawn JP2020508992A (ja) | 2017-02-15 | 2018-01-24 | ざ瘡の処置のためのカンナビノイドの製剤 |
| JP2022166140A Pending JP2022185150A (ja) | 2017-02-15 | 2022-10-17 | ざ瘡の処置のためのカンナビノイドの製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022166140A Pending JP2022185150A (ja) | 2017-02-15 | 2022-10-17 | ざ瘡の処置のためのカンナビノイドの製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220323401A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3582770A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2020508992A (cg-RX-API-DMAC7.html) |
| CN (1) | CN110769819A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018221881B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019017049A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3053503C (cg-RX-API-DMAC7.html) |
| IL (1) | IL268728B2 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ756307A (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220323401A1 (en) * | 2017-02-15 | 2022-10-13 | Botanix Pharmaceuticals Ltd. | Formulations of cannabinoids for the treatment of acne |
| WO2021173800A1 (en) * | 2020-02-25 | 2021-09-02 | Advanced Animal Diagnostics, Inc. | Methods and compositions for identifiying a survivability index for an animal |
| CN114073687A (zh) * | 2020-08-21 | 2022-02-22 | 四川大学华西医院 | 大麻二酚在制备防治玫瑰痤疮的药物中的用途 |
| CN113372196B (zh) * | 2021-07-02 | 2022-09-30 | 江南大学 | 8,9-二氢大麻二酚及其合成方法与应用 |
| JP7736306B2 (ja) * | 2022-11-18 | 2025-09-09 | 株式会社ニューギン | 遊技機 |
| JP7736309B2 (ja) * | 2022-11-18 | 2025-09-09 | 株式会社ニューギン | 遊技機 |
| JP7736310B2 (ja) * | 2022-11-18 | 2025-09-09 | 株式会社ニューギン | 遊技機 |
| JP7736308B2 (ja) * | 2022-11-18 | 2025-09-09 | 株式会社ニューギン | 遊技機 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0104268D0 (en) * | 2001-02-21 | 2001-04-11 | Unilever Plc | Antiperspirant or deodorant compositions |
| DE60228713D1 (de) * | 2001-07-18 | 2008-10-16 | Unilever Nv | Zusammensetzungen für die behandlung von haaren und/oder kopfhaut |
| WO2008024408A2 (en) * | 2006-08-22 | 2008-02-28 | Theraquest Biosciences, Inc. | Pharmaceutical formulations of cannabinoids for application to the skin and method of use |
| WO2009090495A2 (en) * | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
| MX2011011514A (es) * | 2009-04-28 | 2011-11-18 | Alltranz Inc | Formulaciones de canabidiol y metodos para utilizarlas. |
| ES2541485T3 (es) * | 2010-10-19 | 2015-07-21 | Parenteral, A.S. | Composición para el tratamiento de enfermedades inflamatorias, la cual comprende ácidos boswéllicos y cannabidiol |
| US8758826B2 (en) * | 2011-07-05 | 2014-06-24 | Wet Inc. | Cannabinoid receptor binding agents, compositions, and methods |
| US20130184354A1 (en) * | 2012-01-13 | 2013-07-18 | Donna K. Jackson | Silicone and Hylauronic Acid (HLA) Delivery Systems for Products by Sustainable Processes for Medical Uses Including Wound Management |
| CA2890333C (en) * | 2012-11-06 | 2021-03-23 | Rochal Industries, Llc | Delivery of biologically-active agents using volatile, hydrophobic solvents |
| WO2014116653A1 (en) * | 2013-01-22 | 2014-07-31 | Coty Inc. | Topical formulations and methods for the use thereof |
| US20160022627A2 (en) * | 2014-04-18 | 2016-01-28 | Mary's Medicinals LLC | Transdermal cannabinoid patch |
| JP2018507262A (ja) * | 2015-03-02 | 2018-03-15 | アフギン ファーマ, エルエルシーAfgin Pharma, Llc | カンナビノイドを用いた、局所局部的神経作用療法 |
| US20160374958A1 (en) * | 2015-06-23 | 2016-12-29 | Axim Biotechnologies, Inc. | Anti-microbial composition comprising cannabinoids |
| US20220323401A1 (en) * | 2017-02-15 | 2022-10-13 | Botanix Pharmaceuticals Ltd. | Formulations of cannabinoids for the treatment of acne |
| EP3582768A4 (en) * | 2017-02-15 | 2020-11-18 | Botanix Pharmaceuticals Ltd | CANNABINOID FORMULATIONS FOR THE TREATMENT OF DERMATITIS AND INFLAMMATORY SKIN DISEASES |
-
2018
- 2018-01-24 US US16/486,214 patent/US20220323401A1/en active Pending
- 2018-01-24 AU AU2018221881A patent/AU2018221881B2/en not_active Ceased
- 2018-01-24 EP EP18754824.3A patent/EP3582770A4/en not_active Withdrawn
- 2018-01-24 NZ NZ756307A patent/NZ756307A/en not_active IP Right Cessation
- 2018-01-24 CN CN201880023591.0A patent/CN110769819A/zh active Pending
- 2018-01-24 CA CA3053503A patent/CA3053503C/en active Active
- 2018-01-24 BR BR112019017049A patent/BR112019017049A2/pt not_active IP Right Cessation
- 2018-01-24 IL IL268728A patent/IL268728B2/en unknown
- 2018-01-24 JP JP2019544845A patent/JP2020508992A/ja not_active Withdrawn
-
2022
- 2022-10-17 JP JP2022166140A patent/JP2022185150A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020508992A5 (cg-RX-API-DMAC7.html) | ||
| JP2020508994A5 (cg-RX-API-DMAC7.html) | ||
| JP5938497B2 (ja) | 抗真菌医薬組成物 | |
| JP4004182B2 (ja) | 乳化組成物 | |
| NZ597335A (en) | Silicone scar treatment preparation | |
| CN101795669A (zh) | 用于递送药物的组合物 | |
| WO2011157640A2 (en) | A high humectant high internal phase emulsion | |
| JP2014001206A (ja) | ヘア及びボディ用オイル | |
| JP2014518272A5 (cg-RX-API-DMAC7.html) | ||
| JP2018507219A (ja) | 局所製剤 | |
| RU2006137291A (ru) | Безводная фармацевтическая композиция, включающая силиконовый агент и растворимый активный компонент | |
| JP2020501868A (ja) | シリコーン樹脂組成物、その製造方法及びそれを含む瘢痕治療剤 | |
| CN113164351A (zh) | 非铝止汗剂组合物 | |
| JP2020508993A5 (cg-RX-API-DMAC7.html) | ||
| KR20070027587A (ko) | 실리콘제, 코르티코스테로이드 및 비타민 ｄ 또는 이의유도체를 함유하는 건선 치료용 조성물 | |
| JP2008542423A (ja) | 皮膚を通しての薬物の制御放出方法 | |
| EP2498770B1 (en) | Pharmaceutical composition | |
| JP7069176B2 (ja) | 医薬組成物 | |
| JP2019011261A (ja) | 外用組成物 | |
| CN102144952B (zh) | 一种化妆品用w/o乳化剂的制备方法和应用 | |
| WO2025010400A3 (en) | Compositions and methods for improved treatment of skin wounds | |
| JP6284463B2 (ja) | 乳化シェービング剤 | |
| JP7301536B2 (ja) | 外用組成物 | |
| CN118475340A (zh) | 用于护理角蛋白材料的油的组合物 | |
| WO2007085086A1 (en) | A composition including a silicone-based polymer and a method of treating skin disorders using the composition |